Zydus Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication

Zydus Lifesciences has published a notice about a special window for converting physical securities to demat form. The window opened on February 5, 2026, and will remain available until February 4, 2027. This facility is pursuant to an SEBI circular and covers physical securities purchased or sold before April 1, 2019, including previously rejected transfer requests. Securities transferred during this period will be credited only in demat mode and will be locked in for one year from the date of registration. During the lock-in period, these securities cannot be transferred, pledged, or hypothecated. Investors can submit their requests to the company's RTA, MUFG Intime India Private Limited, before the deadline.